COVID-19 Project Team: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 10: Line 10:
{{Multicol}}
{{Multicol}}
* The name of the leaders are written in '''bold''':
* The name of the leaders are written in '''bold''':
'''COVID-19 constant Update''"
 
[[User:Aisha Adigun|Aisha Adigun, M.D]]
'''Constant Update of the Page'''
*[[User:Aisha Adigun|Aisha Adigun, M.D.]]
'''Cardiovascular Disorders of COVID-19 Team Members'''
'''Cardiovascular Disorders of COVID-19 Team Members'''
*[[User:Behjat|Alieh Bahjat, M.D.]]
*[[User:Behjat|Alieh Bahjat, M.D.]]

Revision as of 21:19, 12 August 2020

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Meet The Team

Associate Editor(s)-in-Chief:

  • The name of the leaders are written in bold:

Constant Update of the Page

Cardiovascular Disorders of COVID-19 Team Members

Dermatologic Disorders of COVID-19 Team Members

Frequently Asked Inpatient Questions Team Members

Frequently Asked Outpatient Questions Team Members

Gastrointestinal disorders and COVID-19

Hematologic disorders of COVID-19 Team Members

Nephrologic Disorders of COVID-19 Team Members

Neurologic Disorders and COVID-19 Team Members

Ongoing Clinical Trials of COVID-19 Team Members

Pediatrics and COVID-19

Pulmonary Disorders and COVID-19 Team Members

Endocrinology and COVID-19

Infectious diseases and COVID-19

  • Harmeet, MD
  • Zaida, MD